David Sova
Family Medicine · Grand Rapids, MINPI 1952359895
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $630 and has fallen 91.7% since, to $52 in 2023.
Across 111 payments — averaging $15.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$312
- Novo Nordisk$298
- Pfizer$256
- AstraZeneca$107
- Indivior Inc.$71
- Takeda Pharmaceuticals U.S.A., Inc.$70
- plus $577 from 20 others
What the payments were for
- Food & beverage$1,67899%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 23 | $312 |
| Novo Nordisk | 21 | $298 |
| Pfizer | 16 | $256 |
| AstraZeneca | 7 | $107 |
| Indivior Inc. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $70 |
| Novartis | 5 | $67 |
| AbbVie(2 entities) | 3 | $54 |
| Ultragenyx Pharmaceutical Inc. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $43 |
| Lilly USA, LLC | 3 | $40 |
| Antares Pharma, Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Eisai Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Orexo US, Inc. | 1 | $21 |
| GSK | 1 | $21 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Mylan Specialty L.p. | 1 | $18 |
| Bardy Diagnostics, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Gilead | 1 | $12 |
How this compares
$1,692 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Grand Rapids
- Mary DagenGrand Rapids$265K
- Oren MasonGrand Rapids$97K
- Magalis LlovetGrand Rapids$21K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.